Results 81 to 90 of about 10,410,501 (216)
ABSTRACT Dyspnea, a debilitating symptom of COPD, worsens health‐related quality of life (HRQL), reduces daily physical activity, increases health care utilization, and is more closely associated with survival than airflow limitation. Thus, having treatments that reduce dyspnea in COPD is important.
Elena DeSanti +40 more
wiley +1 more source
Abstract This review covers a seminal study of the relation between exposure to the glucagon‐like peptide 1 (GLP‐1) agonist semaglutide and incident non‐arteritic anterior ischaemic optic neuropathy (NAION) in a neuro‐ophthalmology clinic setting, subsequent studies in unselected populations, a meta‐analysis of clinical trials and pathophysiology ...
Abdullah Amini +2 more
wiley +1 more source
ABSTRACT Optical coherence tomography angiography is a burgeoning imaging modality in Ophthalmology. In this review, we outline the breadth of potential utility for optical coherence tomography angiography for diagnosis and prognostication in neuro‐ophthalmology.
Marzieh Tahmasebi Sarvestani +2 more
wiley +1 more source
A 51‐year‐old female presenting with headache and vision loss
Headache: The Journal of Head and Face Pain, Volume 66, Issue 8, Page 1928-1932, September 2026.
Laurel Ovrom +3 more
wiley +1 more source
Abstract Aims To investigate the putative association between semaglutide and non‐arteritic anterior ischaemic optic neuropathy (NAION). Materials and Methods Data from national health registries in Denmark (2018–2024) and Norway (2018–2022) were used to compare NAION risk in individuals with type 2 diabetes initiating semaglutide versus sodium‐glucose
Emma Simonsen +9 more
wiley +1 more source
Intravitreal bevacizumab therapy in non-arteritic anterior ischemic optic neuropathy
Up to date there is no golden standard for the treatment of non-arteritic ischemic optic neuropathy. Here we report two cases which underwent intravitreal bevacizumab injection for non-arteritic ischemic optic neuropathy. In the first case, visual acuity
Çetin, E.N., Akduman, L.
core
Non-arteritic Ischemic Optic Neuropathy - A Triple Threat?
Recurrent non-arteritic ischemic optic neuropathy (NAION) in the same eye is very rare.1 There have been only a few prior reports of ipsilateral recurrence of non-arteritic ischemic optic neuropathy happening more than twice.2-4 Sometimes worsening of ...
Aubrey Gilbert, MD, PhD
core
Neuro-Ophthalmological Manifestations of Obstructive Sleep Apnea: Current Perspectives
Armin Farahvash,1 Jonathan A Micieli2– 4 1Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; 2Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada; 3Division of Neurology, Department of
Farahvash A, Micieli JA
doaj
Corticosteroid Therapy in Patients with Non-arteritic Anterior Ischemic Optic Neuropathy
Non-arteritic anterior ischemic optic neuropathy is one of the most common conditions affecting the optic nerve in the elderly. It may lead to severe visual loss. Typical symptoms are painless impairment of visual function accompanied by relative afferent pupillary defect, edema of the optic disc and visual field defects.
Vidović, Tomislav +4 more
openaire +4 more sources
Non-arteritic anterior ischemic optic neuropathy (NAION) may rarely develop following severe anemia and hypotension, usually secondary to acute blood loss, usually with a Hemoglobin of less than 7.5 g/dl.
Jae-Chiang Wong; Anita Goyal; Daniel Elefant
core

